Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout
Go back to Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 2.70 --2.7 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $9.58 | |||
| Open | $2.70 | 52 Week Low | $2.34 | |||
| Day High | $2.70 | P/E | N/A | |||
| Day Low | $2.70 | EPS | $-0.34 | |||
| Volume | 9,029 | |||||
